日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Case Series of Breast Carcinoma Erysipeloides Confined Within a Prior Radiation Therapy Treatment Field

既往放射治疗区域内发生的乳腺癌丹毒样病变病例系列

期刊:Advances in Radiation Oncology
影响因子:2.7
doi:10.1016/j.adro.2026.102012
Rummel, Keaton A; Shakeri, Aria; Weiss, Anna; Magnuson, Allison; Hicks, David G; Corbin, Kimberly S; Gergelis, Kimberly R
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Rapid Malignant Transformation of a Biopsy Proven Sporadic Soft Tissue Schwannoma to Spindle Cell MPNST With TP53 Mutation as an Early Event

经活检证实的散发性软组织神经鞘瘤快速恶性转化为梭形细胞恶性周围神经鞘瘤，早期即发现TP53突变。

期刊:International Journal of Surgical Pathology
影响因子:1
doi:10.1177/10668969251340430
Ramineni, Madhurya; Ulici, Veronica; Hicks, David G; Huber, Aaron R; Dieudonne, Gregory; Wang, Xi
细胞生物学
P53
发表日期：2025
文献求助 收藏

Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer

PATHWAY 抗 HER-2/neu (4B5) 抗体的分析和临床验证，用于评估乳腺癌患者接受曲妥珠单抗德鲁替康治疗时 HER2 低表达状态

期刊:Virchows Archiv
影响因子:3.1
doi:10.1007/s00428-023-03671-x
Garrido, Charo; Manoogian, Melissa; Ghambire, Dhiraj; Lucas, Shawn; Karnoub, Maha; Olson, Matthew T; Hicks, David G; Tozbikian, Gary; Prat, Aleix; Ueno, Naoto T; Modi, Shanu; Feng, Wenqin; Pugh, Judith; Hsu, Ching; Tsurutani, Junji; Cameron, David; Harbeck, Nadia; Fang, Qijun; Khambata-Ford, Shirin; Liu, Xuemin; Inge, Landon J; Vitazka, Patrik
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation

Pan-TRK免疫组化结果的验证与解读：实用方法及解读挑战

期刊:Diagnostic Pathology
影响因子:2.3
doi:10.1186/s13000-023-01426-5
Karakas, Cansu; Giampoli, Ellen J; Love, Tanzy; Hicks, David G; Velez, Moises J
IHC
免疫/内分泌
发表日期：2024
文献求助 收藏

The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX(®) Testing

罗切斯特改良版 Magee 算法 (RoMMa)：一种基于结果的策略，用于评估 ER 阳性、HER2 阴性乳腺癌患者在接受 Oncotype DX® 检测时的临床风险和风险分层。

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15030903
Turner, Bradley M; Finkelman, Brian S; Hicks, David G; Numbereye, Numbere; Moisini, Ioana; Dhakal, Ajay; Skinner, Kristin; Sanders, Mary Ann G; Wang, Xi; Shayne, Michelle; Schiffhauer, Linda; Katerji, Hani; Zhang, Huina
肿瘤
HER2
肿瘤免疫
多发性骨髓瘤
乳腺癌
发表日期：2023
文献求助 收藏

The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations

Ki-67与乳腺癌的演变：过去的观察、现在的方向和未来的思考

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15030808
Finkelman, Brian S; Zhang, Huina; Hicks, David G; Turner, Bradley M
Ki-67
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental research

非小细胞肺癌中HER2（ERBB2）免疫组化的研究：与ERBB2突变状态的相关性：实验研究

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000000719
Cardillo, Anthony B; Kovar, Sierra; Roper, Nitin; Hicks, David G; Velez, Moises J
肺癌
肿瘤
IHC
HER2
肿瘤免疫
ERBB2
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing

病理学家们致力于优化肿瘤组织检测流程，以提高诊断准确性和分子检测水平。

期刊:American Journal of Clinical Pathology
影响因子:1.9
doi:10.1093/ajcp/aqaa212
De Las Casas, Luis E; Hicks, David G
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX(®) recurrence score <26

ER阳性乳腺癌患者的风险分层：罗切斯特改良Magee算法（RoMMa）的多中心验证和结果研究，以及Oncotype DX®复发评分<26的预测

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.2323
Turner, Bradley M; Gimenez-Sanders, Mary Ann; Soukiazian, Armen; Breaux, Andrea C; Skinner, Kristin; Shayne, Michelle; Soukiazian, Nyrie; Ling, Marilyn; Hicks, David G
肿瘤
肿瘤免疫
乳腺癌
多发性骨髓瘤
发表日期：2019
文献求助 收藏

A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study

一种利用荧光纳米颗粒定量检测福尔马林固定、石蜡包埋临床样本中HER2蛋白的新型检测方法：一项分析和临床验证研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-018-5172-1
Hicks, David G; Buscaglia, Brandon; Goda, Hideki; McMahon, Loralee; Natori, Takako; Turner, Bradley; Soukiazian, Armen; Okada, Hisatake; Nakano, Yasushi
IF
HER2
发表日期：2018
文献求助 收藏